… Despite the significant therapeutic potential of MitoQ and other TPP-conjugated antioxidants,
there are limitations. The uptake of these compounds is governed by the mitochondrial …

… heart failure has occurred, there are only limited therapeutic … Although the initial insult to the
heart (eg, myocardial … function and no clinically detectable heart failure, over time there is a …

… T2DM accounts for 90% to 95% of all diabetes mellitus cases, 4 for this reason, this
review will focus on pharmacological treatments for T2DM and their impact on heart failure (HF) …

… Carvedilol is a unique cardiovascular drug of multifaceted therapeutic potential. Its major
molecular … of hypertension, ischemic heart disease, and congestive heart failure is based on a …

… the therapeutic potential of iPSCs in animal models of HF. … the Minnesota Living with Heart
Failure Questionnaire. Although … are needed to evaluate the therapeutic potential of CDCs. …

… A major obstacle that hampers development of new therapeutics in heart failure is the
pathophysiologic heterogeneity of the disease. The clinical syndrome of heart failure can be …

… Heart Failure Association of the European Society of Cardiology recently organized an expert
workshop to address the issue of inflammation in heart failure … as novel therapeutic targets …

… pathogenesis of heart failure, prompt careful consideration of gene therapy for heart failure at
this … transport, show therapeutic promise in animal models of heart failure and in myopathic …

… Heart failure can be classified as predominantly left ventricular, right ventricular or … status
of heart: heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced …

… In the present review, we address the potential role of ROS in the … in heart failure (HF)
and their therapeutic targeting. We discuss possible mechanisms underlying the failure of …